Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Farret, A.
Right arrow Articles by Gross, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farret, A.
Right arrow Articles by Gross, R.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 53:S63-S66, 2004
© 2004 by the American Diabetes Association, Inc.


Section II: Beta-Cell Therapeutic Targets Other Than ATP-Sensitive K+ Channels

P2Y Purinergic Potentiation of Glucose-Induced Insulin Secretion and Pancreatic Beta-Cell Metabolism

A. Farret1, M. Vignaud1, S. Dietz2, J. Vignon1, P. Petit1, and R. Gross1

1 Center for Pharmacology and Health Biotechnology, CNRS UMR 5160, Montpellier, France
2 Innodia, Montpellier, France

Purine nucleotides and their analogs increase insulin secretion through activation of pancreatic ß-cell P2Y receptors. The present study aimed at determining the role of glucose metabolism in the response to P2Y agonists and whether ATP-activated K+ channels (KATP channels) are involved in this response. The experiments were performed in the rat isolated pancreas, perfused with a Krebs-bicarbonate buffer supplemented with 2 g/l bovine serum albumin under dynamic glucose conditions from 5 mmol/l baseline to 11 mmol/l. ADPßS (0.5 µmol/l) was selected as a stable and selective P2Y agonist. This compound, ineffective on the 5 mmol/l glucose background, induced a significant threefold increase in insulin release triggered by the glucose challenge. The effect of ADPßS was markedly reduced (P < 0.001) in the presence of an inhibitor of glucose metabolism. In addition to glucose, the ADP analog also amplified the ß-cell insulin response to 15 mmol/l methyl pyruvate (P < 0.05), but it was ineffective on the insulin response to 2.5 mmol/l methyl succinate. A nonmetabolic stimulus was applied using tolbutamide (185 µmol/l). Insulin secretion induced by the KATP channel blocker was strongly reinforced by ADPßS (P < 0.001), which prompted us to check a possible interplay of KATP channels in the effect of ADPßS. In the presence of diazoxide 250 µmol/l and 21 mmol/l KCl, ADPßS still amplified the second phase of glucose-induced insulin secretion (P < 0.001). We conclude that P2Y receptor activation is able to promote insulin secretion through a mechanism, involving ß-cell metabolism and a rise in intracellular calcium; this effect does not result from a direct inhibitory effect on KATP channels.


Address correspondence and reprint requests to Dr. René Gross, Centre de Pharmacologie et Biotechnologie pour la Santé, CNRS UMR 5160, Faculté de Médecine, Institut de Biologie, 4 Boulevard Henri IV, CS89508, 34960 Montpellier Cedex 2, France. E-mail: gross{at}univ-montp1.fr


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2004 by the American Diabetes Association.